The real decision comes down to absorption quality, your timeline for results, and the specific health outcomes you want achieved
Review Summary KLOW - 80mg (blend of TB-500, BPC-157, GHK-Cu, and KPV) - Recovery and Repair Peptide is available from Empower Peptides in the Recovery and Repair Peptides
10.1016/j.ijbiomac.2023.125871 136 IbrahimA.KhalilI
Among these NAEs, exenatide accounted for 10,175 cases (35.14%), liraglutide for 3,686 cases (12.73%), lixisenatide for 256 cases (0.88%), dulaglutide for 6,034 cases (20.84%), semaglutide for 5,935 cases (20.50%), and tirzepatide for 2,867 cases (9.90%)
Nature 576 , S48 (2019)
At present, most the peptides in this review are not FDA-approved for orthopaedic indications